New Antiarrhythmic Agents: Amiodarone, Aprindine, Disopyramide, Ethmozin, Mexiletine, Tocainide, Verapamil

Overview

Journal Am J Cardiol

Specialty Cardiology & Vascular Diseases

Date 1978 May 22

PMID 352121

Citations 30

Authors

D P Zipes

P J Troup

Affiliations

Soon will be listed here.

Abstract

The present status, clinical experience, side effects, clinical pharmacology and electrophysiologic actions of seven new antiarrhythmic agents are reviewed. The drugs selected for comment are amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide and verapamil. Each drug has been shown to have clinical efficacy in suppressing cardiac arrhythmias.

Citing Articles

Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart.

Hesketh L, Wilder C, Ranadive N, Lytra G, Qazimi P, Munro J Sci Rep. 2020; 10(1):8397.

PMID: 32439959 PMC: 7242333. DOI: 10.1038/s41598-020-65190-y.

'White elephants' and a distinguished monkey - or the need for a proactive follow-up in amiodarone therapy.

van Tellingen C Neth Heart J. 2015; 12(10):463-466.

PMID: 25696267 PMC: 2497164.

High-performance liquid chromatographic analysis of tocainide in human plasma.

Conings L, Verbeke N Pharm Res. 2013; 2(6):311-3.

PMID: 24271131 DOI: 10.1023/A:1016353903999.

Adverse effects of class I antiarrhythmic drugs.

Caron J, Libersa C Drug Saf. 1997; 17(1):8-36.

PMID: 9258628 DOI: 10.2165/00002018-199717010-00002.

Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds.

Marshall R, Parratt J Br J Pharmacol. 1980; 71(2):597-600.

PMID: 7470764 PMC: 2044446. DOI: 10.1111/j.1476-5381.1980.tb10978.x.